| Nov 22 |
Pharma Stock Roundup: EU Nod for PFE's Hympavzi, NVS Ups Sales View
|
| Nov 22 |
BridgeBio heart drug approved by FDA, setting up battle with Pfizer
|
| Nov 22 |
Novartis Raises Sales Outlook for Mid-Term, Acquires Kate Therapeutics
|
| Nov 22 |
FDA Accepts Bayer's Application for Label Expansion of Nubeqa
|
| Nov 22 |
Pfizer Inc. (PFE) Jefferies London Healthcare Conference (Transcript)
|
| Nov 22 |
Replimune Stock Rallies on BLA Filing for Melanoma Combo Drug
|
| Nov 22 |
RFK Jr. Spooks Weight-Loss Stocks. Should Eli Lilly, Novo Nordisk Be Worried?
|
| Nov 22 |
Zai Lab and Pfizer to commercialise XACDURO in China
|
| Nov 22 |
The Irish Government Is Unbelievably Rich. It’s Largely Thanks to Uncle Sam.
|
| Nov 21 |
Pfizer: High Dividend And Low Price Might Still Offset The Expanding Risks
|
